LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

Photo from wikipedia

Cancer Center, Gilbert, AZ, United States; Norton Cancer Institute, Louisville, KY, United States; Lymphoma Program, The University of Chicago Medicine, Chicago, IL, United States; John Theurer Cancer Center, Hackensack University… Click to show full abstract

Cancer Center, Gilbert, AZ, United States; Norton Cancer Institute, Louisville, KY, United States; Lymphoma Program, The University of Chicago Medicine, Chicago, IL, United States; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States; Rogel Cancer Center, University of Michigan Cancer Center, Ann Arbor, MI, United States; David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; Hollings Medical Cancer Center, Medical University of South Carolina, Charleston, SC, United States; Cancer Institute, St. Agnes Hospital, Baltimore, MD, United States; Virginia Cancer Institute, Richmond, VA, United States; R&D, Portola Pharmaceuticals, South San Francisco, CA, United States; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Ctr., New York, NY, United States

Keywords: medicine; cancer center; united states; cancer; oncology

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.